Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Scientific Reports
|
May 7, 2016
A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors
Yuming Wei, Daniel C Poon, Rong Fei, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 21, 2018
Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo
Xiaoran Guo, Kenneth K W To, Zhen Chen, et al.
Pflugers Archiv : European Journal of Physiology
|
September 25, 2003
Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells
Shuy-Vang Toan, Kenneth K W To, George P H Leung, et al.
Molecular Cancer
|
September 28, 2024
PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation
Ke Yang, Kai Fu, Hong Zhang, et al.
Acta Pharmaceutica Sinica. B
|
August 16, 2018
Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 <i>in vitro</i> and <i>in vivo</i>
Zhiqiang Zhang, Xiaoran Guo, Kenneth K W To, et al.
Cancer Letters
|
September 22, 2012
Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation
Shan Yu, Lin Jia, Yan Zhang, et al.
Molecular Cancer
|
January 19, 2021
Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer
Shaocong Wu, Min Luo, Kenneth K W To, et al.
International Journal of Biological Macromolecules
|
August 16, 2024
Synergism of colistin and globular endolysins against multidrug-resistant gram-negative bacteria
Pengfei Zhang, Ping Zeng, Christopher K C Lai, et al.
Molecular Therapy Oncolytics
|
February 15, 2020
CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
Lejia Xu, Jiwei Huang, Jie Liu, et al.
Molecular Therapy Oncolytics
|
November 29, 2023
Erratum: CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
Lejia Xu, Jiwei Huang, Jie Liu, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Scientific Reports
|
May 7, 2016
A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors
Yuming Wei, Daniel C Poon, Rong Fei, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 21, 2018
Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo
Xiaoran Guo, Kenneth K W To, Zhen Chen, et al.
Pflugers Archiv : European Journal of Physiology
|
September 25, 2003
Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells
Shuy-Vang Toan, Kenneth K W To, George P H Leung, et al.
Molecular Cancer
|
September 28, 2024
PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation
Ke Yang, Kai Fu, Hong Zhang, et al.
Acta Pharmaceutica Sinica. B
|
August 16, 2018
Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 <i>in vitro</i> and <i>in vivo</i>
Zhiqiang Zhang, Xiaoran Guo, Kenneth K W To, et al.
Cancer Letters
|
September 22, 2012
Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation
Shan Yu, Lin Jia, Yan Zhang, et al.
Molecular Cancer
|
January 19, 2021
Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer
Shaocong Wu, Min Luo, Kenneth K W To, et al.
International Journal of Biological Macromolecules
|
August 16, 2024
Synergism of colistin and globular endolysins against multidrug-resistant gram-negative bacteria
Pengfei Zhang, Ping Zeng, Christopher K C Lai, et al.
Molecular Therapy Oncolytics
|
February 15, 2020
CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
Lejia Xu, Jiwei Huang, Jie Liu, et al.
Molecular Therapy Oncolytics
|
November 29, 2023
Erratum: CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
Lejia Xu, Jiwei Huang, Jie Liu, et al.
Page
of 10